STOCK TITAN

Insider plans $3.9M Rule 144 sale at Company (UTHR) after option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An affiliate of UTHR has filed a Form 144 to sell 8,300 common shares, with an aggregate market value of $3,900,121.86. The proposed sale is to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 01/15/2026. The shares were acquired on the same date via a stock option exercise paid in cash.

The notice also lists prior sales by Paul Mahon over the past three months, including several transactions of 11,000 common shares each between October and December 2025 and an additional 8,300-share sale on 01/02/2026, with individual gross proceeds in the several-million-dollar range. The filer represents that they are not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the UTHR Form 144 filing disclose?

It discloses a planned sale under Rule 144 of 8,300 shares of common stock, with an aggregate market value of $3,900,121.86, to be executed on or about 01/15/2026.

How were the 8,300 UTHR shares being sold acquired?

The 8,300 common shares were acquired on 01/15/2026 through a stock option exercise from the issuer, with the purchase price paid in cash.

Which broker will handle the planned UTHR share sale?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

On which exchange is the planned UTHR stock sale to occur?

The Form 144 indicates that the 8,300 common shares are expected to be sold on the NASDAQ exchange.

How many UTHR shares are outstanding according to this Form 144?

The filing reports that there are 43,056,599 common shares outstanding for the issuer.

What prior UTHR stock sales are reported for the past 3 months?

The notice lists several sales by Paul Mahon, including multiple 11,000-share common stock sales between 10/16/2025 and 12/24/2025, and an 8,300-share sale on 01/02/2026, each with multi-million-dollar gross proceeds.

What representation does the seller make in this UTHR Form 144?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
United Therapeutics Corp.

NASDAQ:UTHR

UTHR Rankings

UTHR Latest News

UTHR Latest SEC Filings

UTHR Stock Data

20.33B
42.14M
1.77%
99.51%
5.97%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SILVER SPRING